141 related articles for article (PubMed ID: 34311135)
1. Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial.
Orłowska E; Czubkowski P; Wołochowska K; Jarzębicka D; Motyl I; Socha P
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101753. PubMed ID: 34311135
[TBL] [Abstract][Full Text] [Related]
2. Use of Lactobacillus casei rhamnosus to Prevent Cholangitis in Biliary Atresia After Kasai Operation.
Lien TH; Bu LN; Wu JF; Chen HL; Chen AC; Lai MW; Shih HH; Lee IH; Hsu HY; Ni YH; Chang MH
J Pediatr Gastroenterol Nutr; 2015 May; 60(5):654-8. PubMed ID: 25534776
[TBL] [Abstract][Full Text] [Related]
3. No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.
Rubin IMC; Mollerup S; Broholm C; Knudsen SB; Baker A; Helms M; Holm MKA; Kallemose T; Westh H; Dahl Knudsen J; Pinholt M; Petersen AM
Microbiol Spectr; 2022 Jun; 10(3):e0234821. PubMed ID: 35475684
[TBL] [Abstract][Full Text] [Related]
4. The Effectiveness of Probiotic
Cukrowska B; Ceregra A; Maciorkowska E; Surowska B; Zegadło-Mylik MA; Konopka E; Trojanowska I; Zakrzewska M; Bierła JB; Zakrzewski M; Kanarek E; Motyl I
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916192
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048].
Salazar-Lindo E; Miranda-Langschwager P; Campos-Sanchez M; Chea-Woo E; Sack RB
BMC Pediatr; 2004 Sep; 4():18. PubMed ID: 15345099
[TBL] [Abstract][Full Text] [Related]
6. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.
Sindhu KN; Sowmyanarayanan TV; Paul A; Babji S; Ajjampur SS; Priyadarshini S; Sarkar R; Balasubramanian KA; Wanke CA; Ward HD; Kang G
Clin Infect Dis; 2014 Apr; 58(8):1107-15. PubMed ID: 24501384
[TBL] [Abstract][Full Text] [Related]
7. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation.
Laursen MF; Laursen RP; Larnkjær A; Michaelsen KF; Bahl MI; Licht TR
BMC Microbiol; 2017 Aug; 17(1):175. PubMed ID: 28818050
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.
Sentongo TA; Cohran V; Korff S; Sullivan C; Iyer K; Zheng X
J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):41-7. PubMed ID: 18162832
[TBL] [Abstract][Full Text] [Related]
9. Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis.
Ray KJ; Santee C; McCauley K; Panzer AR; Lynch SV
BMC Pulm Med; 2022 Jul; 22(1):287. PubMed ID: 35902830
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain.
Francavilla R; Miniello V; Magistà AM; De Canio A; Bucci N; Gagliardi F; Lionetti E; Castellaneta S; Polimeno L; Peccarisi L; Indrio F; Cavallo L
Pediatrics; 2010 Dec; 126(6):e1445-52. PubMed ID: 21078735
[TBL] [Abstract][Full Text] [Related]
11. Infant behavioral state and stool microbiome in infants receiving Lactocaseibacillus rhamnosus GG in formula: randomized controlled trial.
Shulman RJ; Chichlowski M; Orozco FG; Harris CL; Wampler JL; Bokulich NA; Berseth CL
BMC Pediatr; 2022 Oct; 22(1):580. PubMed ID: 36207675
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of
Rauseo AM; Hink T; Reske KA; Seiler SM; Bommarito KM; Fraser VJ; Burnham CD; Dubberke ER;
Infect Control Hosp Epidemiol; 2022 Feb; 43(2):167-173. PubMed ID: 33820576
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial.
Carucci L; Nocerino R; Paparo L; De Filippis F; Coppola S; Giglio V; Cozzolino T; Valentino V; Sequino G; Bedogni G; Russo R; Ercolini D; Berni Canani R
Pediatr Allergy Immunol; 2022 Aug; 33(8):e13836. PubMed ID: 36003050
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial.
Hojsak I; Snovak N; Abdović S; Szajewska H; Misak Z; Kolacek S
Clin Nutr; 2010 Jun; 29(3):312-6. PubMed ID: 19896252
[TBL] [Abstract][Full Text] [Related]
15. Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.
Doron S; Hibberd PL; Goldin B; Thorpe C; McDermott L; Snydman DR
Antimicrob Agents Chemother; 2015 Aug; 59(8):4593-9. PubMed ID: 26014940
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial.
Daniel M; Szymanik-Grzelak H; Turczyn A; Pańczyk-Tomaszewska M
BMC Urol; 2020 Oct; 20(1):168. PubMed ID: 33097017
[TBL] [Abstract][Full Text] [Related]
17. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lee BB; Toh SL; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber G; Kaur J; Boswell-Ruys C; Goodall S; Middleton J; Tudehope M; Kotsiou G
BMC Urol; 2016 Apr; 16():18. PubMed ID: 27084704
[TBL] [Abstract][Full Text] [Related]
18. Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial.
Pärtty A; Lehtonen L; Kalliomäki M; Salminen S; Isolauri E
Pediatr Res; 2015 Oct; 78(4):470-5. PubMed ID: 26151493
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children.
Szachta P; Ignyś I; Cichy W
J Clin Gastroenterol; 2011; 45(10):872-7. PubMed ID: 21814146
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial.
Chen MJ; Chen CC; Huang YC; Tseng CC; Hsu JT; Lin YF; Fang YJ; Wu MS; Liou JM;
Helicobacter; 2021 Dec; 26(6):e12857. PubMed ID: 34708471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
